EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia

Floor L F van Baarle iD, Emma K van de Weerdt, Walter J F M van der Velden, Roelof A Ruiterkamp iD, Pieter R Tuinman, Paula F Ypma iD, Walter M van den Bergh, Astrid M P Demandt, Emile D Kerver, A J Gerard Jansen iD, Peter E Westerweel, Sesmu M Arbous und 8 weitere

New England Journal of Medicine · 25.05.2023 · 388 (21) · 1956-1965

DOI: 10.1056/nejmoa2214322 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift New England Journal of Medicine, erschienen am 25.05.2023. Verfasst von Floor L F van Baarle und 19 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Intensive Care Medicine (F.L.F.B., E.K.W., J.M.B., A.P.J.V.) and Hematology (B.J.B.) and the Laboratory of Experimental Inten…. Hauptthemen laut MEDLINE: Platelet Transfusion, Thrombocytopenia, Catheterization, Central Venous. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence. The routine use of ultrasound guidance has decreased CVC-related bleeding complications. METHODS: In a multicenter, randomized, controlled, noninferiority trial, we randomly assigned patients with severe thrombocytopenia (platelet count, 10,000 to 50,000 per cubic millimeter) who were being treated on the hematology ward or in the intensive care unit to receive either one unit of prophylactic platelet transfusion or no platelet transfusion before ultrasound-guided CVC placement. The primary outcome was catheter-related bleeding of grade 2 to 4; a key secondary outcome was grade 3 or 4 bleeding. The noninferiority margin was an upper boundary of the 90% confidence interval of 3.5 for the relative risk. RESULTS: We included 373 episodes of CVC placement involving 338 patients in the per-protocol primary analysis. Catheter-related bleeding of grade 2 to 4 occurred in 9 of 188 patients (4.8%) in the transfusion group and in 22 of 185 patients (11.9%) in the no-transfusion group (relative risk, 2.45; 90% confidence interval [CI], 1.27 to 4.70). Catheter-related bleeding of grade 3 or 4 occurred in 4 of 188 patients (2.1%) in the transfusion group and in 9 of 185 patients (4.9%) in the no-transfusion group (relative risk, 2.43; 95% CI, 0.75 to 7.93). A total of 15 adverse events were observed; of these events, 13 (all grade 3 catheter-related bleeding [4 in the transfusion group and 9 in the no-transfusion group]) were categorized as serious. The net savings of withholding prophylactic platelet transfusion before CVC placement was $410 per catheter placement. CONCLUSIONS: The withholding of prophylactic platelet transfusion before CVC placement in patients with a platelet count of 10,000 to 50,000 per cubic millimeter did not meet the predefined margin for noninferiority and resulted in more CVC-related bleeding events than prophylactic platelet transfusion. (Funded by ZonMw; PACER Dutch Trial Register number, NL5534.).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet TransfusionThrombocytopeniaCatheterization, Central VenousHumansPlatelet CountUltrasonography, InterventionalHemorrhage

Autor:innen und Institutionen

  • From the Departments of Intensive Care Medicine (F.L.F.B., E.K.W., J.M.B., A.P.J.V.) and Hematology (B.J.B.) and the Laboratory of Experimental Intensive Care and Anesthesiology (F.L.F.B., E.K.W., A.P.J.V.), Amsterdam U…

ORCID-Profile: Floor L F van Baarle, Roelof A Ruiterkamp, Paula F Ypma, A J Gerard Jansen, Alexander P J Vlaar

Förderung

  • ZonMw

Zitieren

APA

van Baarle, F. L. F., van de Weerdt, E. K., van der Velden, W. J. F. M., Ruiterkamp, R. A., Tuinman, P. R., Ypma, P. F., van den Bergh, W. M., Demandt, A. M. P., Kerver, E. D., Jansen, A. J. G., Westerweel, P. E., Arbous, S. M., Determann, R. M., van Mook, W. N. K. A., Koeman, M., Mäkelburg, A. B. U., van Lienden, K. P., Binnekade, J. M., Biemond, B. J., & Vlaar, A. P. J. (2023). Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. New England Journal of Medicine, 388(21), 1956-1965. https://doi.org/10.1056/nejmoa2214322

Vancouver

van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, et al. Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. New England Journal of Medicine. 2023;388(21):1956-1965. doi:10.1056/nejmoa2214322

BibTeX
@article{vanBaarle2023,
  author = {van Baarle, Floor L F and van de Weerdt, Emma K and van der Velden, Walter J F M and Ruiterkamp, Roelof A and Tuinman, Pieter R and Ypma, Paula F and van den Bergh, Walter M and Demandt, Astrid M P and Kerver, Emile D and Jansen, A J Gerard and Westerweel, Peter E and Arbous, Sesmu M and Determann, Rogier M and van Mook, Walther N K A and Koeman, Mirelle and Mäkelburg, Anja B U and van Lienden, Krijn P and Binnekade, Jan M and Biemond, Bart J and Vlaar, Alexander P J},
  title = {Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {21},
  pages = {1956--1965},
  doi = {10.1056/nejmoa2214322}
}
Kostenlos starten →